Scientists have discovered the first new antibiotic in nearly 30 years called Teixobactin. It is effective against many common bacterial infections like tuberculosis and C. difficile. Teixobactin works via a novel dual mechanism attacking the building blocks of bacterial cell walls. Testing on mice showed it cleared infections without side effects. This discovery is significant because Teixobactin does not encounter any detectable resistance, which could lead to a new generation of antibiotics. It may be available for human use within 5 years.